# K960978: Wright Plaster of Paris Pellets (Subject to Revision)

- Pathway: 510(k) (Traditional)
- Applicant: Wrightmedicaltechnologyinc
- Decided: Jun 21, 1996 after 102 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
320 later devices descend from it; 2 cite it directly.
0 of 321 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Plaster of Paris Pellets (Ethicon): named in the summary without a submission number

## Most influential descendants
- K980817: Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10, 5RG15, 5G15L, 5RG20, 5RG30, 5RG30L (1998), 312 descendants of its own
- K021336: Novabone-Resorbable Bone Graft Substitute (2002), 162 descendants of its own
- K030131: Ossatura BCP Bone Void Filler (2003), 133 descendants of its own
- K052494: Novabone-Bioactive Synthetic Graft (2005), 123 descendants of its own
- K060728: Novabone Putty - Bioactive Synthetic Graft (2006), 120 descendants of its own

## Indications for use
Wright Plaster of Paris Pellets are intended to be gently packed into non-loadbearing long bone voids. These bone voids may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The Wright Plaster of Paris Pellets provide a bone filler that resorbs and is replaced with bone during the healing process.

Source page: https://510kreport.com/device/K960978
Methodology: https://510kreport.com/methodology